Georg Steinkellner
Overview
Explore the profile of Georg Steinkellner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
472
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steinkellner G, Kroutil W, Gruber K, Gruber C
Nature
. 2025 Jan;
637(8046):548.
PMID: 39809910
No abstract available.
2.
Parigger L, Krassnigg A, Hetmann M, Hofmann A, Gruber K, Steinkellner G, et al.
Viruses
. 2024 Aug;
16(8).
PMID: 39205160
Advancing climate change increases the risk of future infectious disease outbreaks, particularly of zoonotic diseases, by affecting the abundance and spread of viral vectors. Concerningly, there are currently no approved...
3.
Hetmann M, Parigger L, Sirelkhatim H, Stern A, Krassnigg A, Gruber K, et al.
Sci Data
. 2024 Jun;
11(1):591.
PMID: 38844754
Human proteins are crucial players in both health and disease. Understanding their molecular landscape is a central topic in biological research. Here, we present an extensive dataset of predicted protein...
4.
Parigger L, Krassnigg A, Grabuschnig S, Gruber K, Steinkellner G, Gruber C
Microbiol Spectr
. 2023 Oct;
11(6):e0231523.
PMID: 37874150
The 2022 outbreak of the monkeypox virus already involves, by April 2023, 110 countries with 86,956 confirmed cases and 119 deaths. Understanding an emerging disease on a molecular level is...
5.
Schimunek J, Seidl P, Elez K, Hempel T, Le T, Noe F, et al.
Mol Inform
. 2023 Oct;
43(1):e202300262.
PMID: 37833243
The COVID-19 pandemic continues to pose a substantial threat to human lives and is likely to do so for years to come. Despite the availability of vaccines, searching for efficient...
6.
Kochl K, Schopper T, Durmaz V, Parigger L, Singh A, Krassnigg A, et al.
Sci Rep
. 2023 Jan;
13(1):774.
PMID: 36641503
Treatment of COVID-19 with a soluble version of ACE2 that binds to SARS-CoV-2 virions before they enter host cells is a promising approach, however it needs to be optimized and...
7.
Parigger L, Krassnigg A, Schopper T, Singh A, Tappler K, Kochl K, et al.
Front Med (Lausanne)
. 2023 Jan;
9:1061142.
PMID: 36590977
Introduction: The current coronavirus pandemic is being combated worldwide by nontherapeutic measures and massive vaccination programs. Nevertheless, therapeutic options such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main-protease (M)...
8.
Durmaz V, Kochl K, Krassnigg A, Parigger L, Hetmann M, Singh A, et al.
Sci Rep
. 2022 Aug;
12(1):14534.
PMID: 36008461
To date, more than 263 million people have been infected with SARS-CoV-2 during the COVID-19 pandemic. In many countries, the global spread occurred in multiple pandemic waves characterized by the...
9.
Singh A, Steinkellner G, Kochl K, Gruber K, Gruber C
Sci Rep
. 2021 Feb;
11(1):4320.
PMID: 33619331
Since the worldwide outbreak of the infectious disease COVID-19, several studies have been published to understand the structural mechanism of the novel coronavirus SARS-CoV-2. During the infection process, the SARS-CoV-2...
10.
Braunschmid V, Fuerst S, Perz V, Zitzenbacher S, Hoyo J, Fernandez-Sanchez C, et al.
Int J Mol Sci
. 2020 Aug;
21(16).
PMID: 32796622
Ascorbate oxidases are an enzyme group that has not been explored to a large extent. So far, mainly ascorbate oxidases from plants and only a few from fungi have been...